Trial intelligence / Profile preview

UGT1A1 genotype-guided CPT-11 regimens in metastatic colorectal cancer

jRCT1080220913

Sponsor
Daiichi Sankyo Co., Ltd.
Start
Nov 2009
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of irinotecan in colorectal cancer (CRC) (3 arms), sponsored by Daiichi Sankyo Co., Ltd.

02

Drugs

irinotecan
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on jRCT1080220913.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080220913.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call